HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multi-Omics Analysis to Characterize Cigarette Smoke Induced Molecular Alterations in Esophageal Cells.

Abstract
Though smoking remains one of the established risk factors of esophageal squamous cell carcinoma, there is limited data on molecular alterations associated with cigarette smoke exposure in esophageal cells. To investigate molecular alterations associated with chronic exposure to cigarette smoke, non-neoplastic human esophageal epithelial cells were treated with cigarette smoke condensate (CSC) for up to 8 months. Chronic treatment with CSC increased cell proliferation and invasive ability of non-neoplastic esophageal cells. Whole exome sequence analysis of CSC treated cells revealed several mutations and copy number variations. This included loss of high mobility group nucleosomal binding domain 2 (HMGN2) and a missense variant in mediator complex subunit 1 (MED1). Both these genes play an important role in DNA repair. Global proteomic and phosphoproteomic profiling of CSC treated cells lead to the identification of 38 differentially expressed and 171 differentially phosphorylated proteins. Bioinformatics analysis of differentially expressed proteins and phosphoproteins revealed that most of these proteins are associated with DNA damage response pathway. Proteomics data revealed decreased expression of HMGN2 and hypophosphorylation of MED1. Exogenous expression of HMGN2 and MED1 lead to decreased proliferative and invasive ability of smoke exposed cells. Immunohistochemical labeling of HMGN2 in primary ESCC tumor tissue sections (from smokers) showed no detectable expression while strong to moderate staining of HMGN2 was observed in normal esophageal tissues. Our data suggests that cigarette smoke perturbs expression of proteins associated with DNA damage response pathways which might play a vital role in development of ESCC.
AuthorsAafaque Ahmad Khan, Krishna Patel, Shankargouda Patil, Niraj Babu, Kiran K Mangalaparthi, Hitendra Singh Solanki, Vishalakshi Nanjappa, Anjali Kumari, Malini Manoharan, Coral Karunakaran, Saktivel Murugan, Bipin Nair, Rekha V Kumar, Manjusha Biswas, David Sidransky, Ravi Gupta, Rohit Gupta, Arati Khanna-Gupta, Prashant Kumar, Aditi Chatterjee, Harsha Gowda
JournalFrontiers in oncology (Front Oncol) Vol. 10 Pg. 1666 ( 2020) ISSN: 2234-943X [Print] Switzerland
PMID33251127 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Khan, Patel, Patil, Babu, Mangalaparthi, Solanki, Nanjappa, Kumari, Manoharan, Karunakaran, Murugan, Nair, Kumar, Biswas, Sidransky, Gupta, Gupta, Khanna-Gupta, Kumar, Chatterjee and Gowda.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: